In 1953, researchers at the University of Iowa reported the first pregnancies from human sperm frozen in dry ice. A child born that year arrived through a technique older than the internet and older than the first successful heart transplant. The science behind sperm banking was ready before most of the men reading this were born, and the conversation about it in far too many oncology clinics still has not caught up.
Decades of surveys of oncology practice have found that many young men diagnosed with cancer never hear that they could bank sperm before treatment starts. The failure sits in the handoff between oncology and reproductive medicine, not in the science. The fix has been on the table since the 1950s.
The freezer worked before the moon landing
In 1949, three researchers in England, Polge, Smith, and Parkes, found that glycerol could protect sperm from freezing damage. They published the result in Nature. Before that, freezing sperm was a dead end. Ice crystals shredded the cells.
Four years later, Bunge and Sherman at the University of Iowa used that insight to freeze human sperm in dry ice and reported the first pregnancies. By the 1960s, Jerome Sherman had developed liquid nitrogen storage at roughly minus 196 degrees Celsius. Commercial sperm banks opened in the 1970s.
New tools kept stacking on top. The first IVF birth happened in 1978 with Louise Brown. Then in 1992, Palermo and colleagues published the first pregnancies from intracytoplasmic sperm injection, or ICSI, in The Lancet. A single sperm injected directly into an egg could produce a child. That lowered the bar for men with very low sperm counts. A thin sample could still be enough.
The core workflow has not changed since 1953. Collect a sample, add a protectant, freeze it, thaw it later. The technology has never been the bottleneck.
Cancer survival changed the question
For most of the 20th century, a cancer diagnosis in a young man meant one question: survival. In the mid-1970s, five-year survival for childhood cancers sat around 58 percent. Data from the National Cancer Institute's SEER program now put that number at roughly 85 percent. More people survive. More men live long enough to wonder whether they can have children.
The field of oncofertility formed to answer that question. Teresa Woodruff, a reproductive scientist at Northwestern University, coined the term in 2006. The Oncofertility Consortium launched in 2007. The American Society of Clinical Oncology published its first fertility preservation guidelines in 2006, recommending that oncologists discuss sperm banking with men whose treatment could damage fertility. Those guidelines were updated in 2018.
The science has been settled since the 1950s. The guidelines have existed since 2006. The weak link is what happens between the guideline and the actual conversation.
The referral gap is a conversation gap
In a 2002 survey of more than 700 oncologists published in the Journal of Clinical Oncology, fewer than half said they routinely brought up sperm banking with men who were eligible for it. That was six years after the first ASCO guidelines were already in circulation. Later surveys have found more awareness, but the gap between knowing about fertility preservation and actually referring men has not closed.
A cancer diagnosis creates time pressure. Treatment starts quickly. Fertility can feel secondary when a tumor is growing. Some clinicians assume men do not care. Some never received training in what to say or where to refer.
Men themselves can hesitate too. Producing a sample in a clinic during a cancer workup is awkward. Some worry that banking will delay treatment, even when the delay is measured in days. Others simply do not know the option exists.
The burden should not fall on the patient to know the field. The guidelines put the responsibility on the clinical team. In practice, the conversation still depends on which oncologist a man happens to get.
Sperm quality is already under pressure at diagnosis
Most people assume a man's fertility is intact until chemotherapy damages it. The research does not support that. Multiple studies over decades have found that men with cancer often have reduced sperm concentration, motility, and DNA integrity at diagnosis, before any treatment begins. The disease itself, along with fever, inflammation, and systemic stress, can suppress sperm production.
That matters for timing. If sperm quality is already compromised before treatment, the most reliable window for banking is early, before the first infusion or radiation session. Waiting until after treatment is a much weaker bet.
Cancer types, stages, and individual cases vary. A doctor should assess each situation. But the pattern in the literature has been consistent for decades.
What banking actually involves
The process is not experimental. It has four steps.
- Provide a semen sample at a fertility clinic or sperm bank.
- The sample is analyzed, mixed with a cryoprotectant, and frozen in liquid nitrogen.
- Samples can be collected on consecutive days if needed.
- When the time comes, thawed sperm can be used for intrauterine insemination or for IVF with ICSI.
Frozen sperm can be stored for decades. Multiple published case reports describe live births from samples stored for 20 years or more.
Since Palermo's 1992 paper, ICSI has meant that even a small number of motile sperm may be enough to fertilize an egg. For that reason, banking can still be worthwhile when the pre-treatment analysis looks thin.
The useful distinction is between banking before treatment and banking after. The first is established medicine. The second is a salvage attempt with far less reliable results.
The prepubertal frontier
There is one group the standard technology cannot help. Boys who have not gone through puberty do not yet produce sperm. For them, testicular tissue cryopreservation is the experimental option. A network of academic centers in the United States has been offering this since the 2010s. Early experience was published in Human Reproduction in 2019. No human fertility restoration from frozen immature testicular tissue has been reported yet.
The future direction comes from mouse work. In 2011, Sato and colleagues reported producing live mouse offspring from sperm generated in vitro from testicular tissue. That result has not been replicated in humans. The honest summary is that this is a long bet, not a current standard of care.
The cultural lag is the actual problem
The technology is 70 years old. The guidelines are 20 years old. The referral data still shows a gap. The gap has cultural and systemic roots. The science was never the bottleneck.
Historically, cancer care treated fertility as a women's issue. Reproductive conversations centered on eggs, periods, and ovarian function. Men were assumed not to care. When researchers actually ask young male survivors, fertility consistently ranks among their top long-term concerns. The assumption collapses under the data.
There is also a timing problem baked into the culture of oncology. The 1950s model was about surviving at all costs. Now survival is the baseline. The conversation about life after cancer, including fatherhood, has moved on paper but not everywhere in practice.
Questions worth raising before treatment starts
For a man facing a new cancer diagnosis who wants to keep the option of fatherhood, the evidence points to a few questions worth raising with the oncology team.
- Which treatments in the proposed plan can affect sperm production?
- Is there time to bank sperm before starting treatment?
- What is the nearest fertility clinic that works with cancer patients, and does insurance or a support program help with the cost?
Organizations like LIVESTRONG Fertility, the Alliance for Fertility Preservation, and the Oncofertility Consortium maintain directories and funding information. The conversation is easiest before treatment starts, not after.
Banking preserves the option. It does not promise a child. But the option is the point. The first frozen-sperm baby from 1953 is a reminder that the science has been ready for generations. The open question is whether every man gets the conversation before the first infusion.
This content is for educational purposes only and is not medical advice. If you are facing treatment decisions, talk with your oncology team and a fertility specialist.
Frequently asked questions
can you bank sperm after starting cancer treatment
Banking before treatment is far more reliable because sperm quality can already be reduced at diagnosis and chemotherapy can damage production further. If treatment has already started, your oncology team can still tell you whether banking makes sense for your situation. Post-treatment banking is generally a weaker bet.
how long can frozen sperm stay viable
Frozen sperm can be stored for decades. Multiple published case reports describe live births from samples stored for 20 years or more. Liquid nitrogen storage keeps samples at roughly minus 196 degrees Celsius.
does banking sperm delay cancer treatment
Usually not. Collection can often be done within a few days, and clinics that work with cancer patients know how to coordinate with the oncology schedule. The delay is typically measured in days, not weeks.
what questions should men ask about fertility preservation after a cancer diagnosis
Ask which treatments in the plan can affect sperm production, whether there is time to bank before starting, where the nearest fertility clinic is, and whether insurance or a support program helps with cost. Organizations like LIVESTRONG Fertility and the Oncofertility Consortium keep directories and funding information.